{% extends "base.htm" %}

{% load static %}
{% block title %}Methodology & Maturity level{% endblock %}

{% block content %}
<link rel="stylesheet" type="text/css" href="{% static 'admin/methodology.css' %}?v={% now 'U' %}">

<div class="container">
    <h1>Advancing Cancer Care: Insights from Global Best Practices</h1>
    <h2>Comparative Maturity Index Across Five Cancer Types â€“ Breast, Lung, Colorectal, Prostate, and Gastric</h2>
    <div class="goal-objective">
        <h1>Our Objective</h1>
        <p>To deliver a comprehensive, comparative analysis of cancer care systems across <b>42 diverse countries</b>,
            with a
            strong focus on five of the most burdensome cancers globally, <strong>breast</strong>,
            <strong>lung</strong>, <strong>colorectal</strong>, <strong>prostate</strong>, and
            <strong>gastric</strong>. This study applies a unified 7-pillar maturity index to assess how health systems
            perform in areas
            such as <strong>infrastructure</strong>, access to <strong>diagnostics and treatment</strong>,
            <strong>clinical practices</strong>, and <strong>financial protection</strong>.
            While drawing lessons from a wide range of health system models, this presentation puts a spotlight on the
            Focus countries. <b>The aim is to leverage global benchmarks to identify opportunities for reform,
                innovation,
                and improved equity in the cancer care continuum.</b>
        </p>

        <h1>Goal</h1>
        <div class="goal-cards">
            <div class="goal-card">
                <div class="card-header">
                    <h2>Highlight the Global Cancer Care Landscape Using Data-Driven Insights</h2>
                </div>
                <p>Compare cancer care maturity across 43 countries using standardized maturity scores, identifying
                    global trends, strengths, and systemic gaps to guide international alignment with best practices.
                </p>
            </div>

            <div class="goal-card">
                <div class="card-header">
                    <h2>Benchmark System Maturity Across Seven Strategic Pillars Reflecting Readiness, Equity, and
                        Innovation</h2>
                </div>
                <p>Apply a unified maturity framework to assess performance in infrastructure, treatment access,
                    survival outcomes, biomarker utilization, clinical guidelines, reimbursement systems, and screening
                    programs, enabling robust cross-country and regional comparisons</p>
            </div>

            <div class="goal-card">
                <div class="card-header">
                    <h2>Identify Globally and Regionally Relevant Solutions by Learning from Peer Countries</h2>
                </div>
                <p>Examine challenges and successes in comparable health systems across regions to extract feasible,
                    context-sensitive strategies applicable to diverse settings.</p>
            </div>

            <div class="goal-card">
                <div class="card-header">
                    <h2>Drive Actionable Discussions to Inform National, Regional, and Global Cancer Care Strategies
                    </h2>
                </div>
                <p>Engage policymakers, healthcare leaders, and patient advocates to co-develop targeted policy and
                    program priorities, leveraging real-world data and global best practices for impactful cancer care
                    improvement.</p>
            </div>
        </div>
    </div>

    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture2.png' %}" alt="Infrastructure Icon">
            Infrastructure
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>Specialized Cancer Centers</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Genetic & Molecular Testing Infrastructure</td>
                <td>1-5</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture3.png' %}" alt="Treatment Icon">
            Treatment Access, Research Funding & Awareness
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>Treatment Access</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Research Funding</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Awareness Campaigns</td>
                <td>1-5</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture4.png' %}" alt="Survival Icon">
            Survival, Early Detection & Palliative Care
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>Survival Rates</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Early Detection</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Palliative Care</td>
                <td>1-5</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture5.png' %}" alt="Biomarker Icon">
            Biomarker Utilization
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>HER2</td>
                <td>% Coverage</td>
            </tr>
            <tr>
                <td>Estrogen Receptor (ER)</td>
                <td>% Coverage</td>
            </tr>
            <tr>
                <td>Progesterone Receptor (PR)</td>
                <td>% Coverage</td>
            </tr>
            <tr>
                <td>BRCA1</td>
                <td>% Coverage</td>
            </tr>
            <tr>
                <td>BRCA2</td>
                <td>% Coverage</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture6.png' %}" alt="Clinical Icon">
            Clinical Guidelines
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>National Guideline Implementation</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Feasibility of Integration</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Adoption of International Guidelines</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>Engagement with Updates</td>
                <td>1-5</td>
            </tr>
            <tr>
                <td>ESMO Guidelines Implementation</td>
                <td>1-5</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            <img src="{% static 'admin/img/Picture7.png' %}" alt="Reimbursement Icon">
            Reimbursement Systems
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>Reimbursement</td>
                <td>1-3</td>
            </tr>
            <tr>
                <td>No-Cost Access</td>
                <td>1-3</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            Cancer Screening
        </div>
        <table class="measures-table">
            <tr>
                <th>Measure</th>
                <th>Scale</th>
            </tr>
            <tr>
                <td>Type of Screening Program</td>
                <td>Descriptive</td>
            </tr>
        </table>
    </div>
    <div class="section">
        <div class="section-title">
            Regional Coverage
        </div>
        <div class="table-map-div">
            <table class="regions-table">
                <tr>
                    <th>North America</th>
                    <th>Europe</th>
                    <th>Asia</th>
                    <th>Africa</th>
                    <th>Latin America & Caribbean</th>
                    <th>Oceania</th>
                </tr>
                <tr>
                    <td>United States</td>
                    <td>United Kingdom</td>
                    <td>Japan</td>
                    <td>South Africa</td>
                    <td>Mexico</td>
                    <td>Australia</td>
                </tr>
                <tr>
                    <td>Canada</td>
                    <td>Germany</td>
                    <td>South Korea</td>
                    <td>Kenya</td>
                    <td>Brazil</td>
                    <td>New Zealand</td>
                </tr>
                <tr>
                    <td></td>
                    <td>France</td>
                    <td>China</td>
                    <td>Nigeria</td>
                    <td>Argentina</td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Netherland</td>
                    <td>India</td>
                    <td>Egypt</td>
                    <td>Chile</td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Sweden</td>
                    <td>Singapore</td>
                    <td>Morocco</td>
                    <td>Colombia</td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Italy</td>
                    <td>Thailand</td>
                    <td>Algeria</td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Spain</td>
                    <td>Saudi Arabia</td>
                    <td>Ethiopia</td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Poland</td>
                    <td>UAE</td>
                    <td>Rwanda</td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Greecs</td>
                    <td>Syria</td>
                    <td>Uganda</td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Russia</td>
                    <td>Indonesia</td>
                    <td></td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Serbia</td>
                    <td>Vietnam</td>
                    <td></td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Philippines</td>
                    <td></td>
                    <td></td>
                    <td></td>
                    <td></td>
                </tr>
                <tr>
                    <td></td>
                    <td>Malaysia</td>
                    <td></td>
                    <td></td>
                    <td></td>
                    <td></td>
                </tr>
            </table>
            <img src="{% static 'admin/img/worldmap.png' %}" alt="World Map" class="map-img">
        </div>
    </div>

    <div>
        <h1>Maturity Level Framework</h1>
        <table>
            <tr>
                <th>Pillar</th>
                <th class="level-header">Level 1 (Critical) - Least Developed</th>
                <th class="level-header">Level 2 (Emerging) - Underdeveloped</th>
                <th class="level-header">Level 3 (Intermediate) - Developing</th>
                <th class="level-header">Level 4 (Advanced) - Well Developed</th>
                <th class="level-header">Level 5 (Leading) - Highly Developed</th>
            </tr>
            <tr>
                <td class="pillar">Infrastructure</td>
                <td>No specialized cancer infrastructure; basic hospitals lack diagnostic or oncology units.</td>
                <td>Select tertiary hospitals offer basic cancer services; most regions underserved.</td>
                <td>Moderate access in regional centers; basic pathology, imaging, and oncology units exist.</td>
                <td>Well-distributed cancer centers with full diagnostics and treatment capabilities.</td>
                <td>Nationwide network of specialized cancer institutes with digital and AI-enabled systems.</td>
            </tr>
            <tr>
                <td class="pillar">Treatment Access, Research Funding, and Awareness Campaigns</td>
                <td>Only generic chemotherapy is available; no clinical trials or awareness initiatives.</td>
                <td>Some chemotherapy options; few research grants, limited campaigns.</td>
                <td>Public access to chemotherapy and some targeted therapies; national research budgets growing.</td>
                <td>Widespread access to modern treatments; robust national research and funded awareness campaigns.
                </td>
                <td>Cutting-edge treatments (immunotherapy, research pipeline, high-profile national campaigns).</td>
            </tr>
            <tr>
                <td class="pillar">Survival Rates, Early Detection, and Palliative Care</td>
                <td>Survival <10%, late-stage diagnosis is the norm; palliative care absent.</td>
                <td>Survival 10-20%, early detection rare; some hospitals offer pain management.</td>
                <td>Survival 20-35%, early detection phase; regional palliative services exist.</td>
                <td>Survival 35-50%; structured early detection and nationwide palliative care programs.</td>
                <td>Survival >50% population-based early detection, full palliative and survivorship programs
                    integrated.</td>
            </tr>
            <tr>
                <td class="pillar">Utilization of Biomarkers</td>
                <td>No biomarker testing; no labs or capacity for KRAS, EGFR, ALK, etc.</td>
                <td>Testing limited to private labs or funded projects; no reimbursement.</td>
                <td>Select biomarkers (e.g., EGFR) available in cities; partial coverage exists.</td>
                <td>Routine biomarker use (EGFR, ALK, PD-L1) for eligible cases with regional access.</td>
                <td>Universal biomarker integration, rapid, reimbursed, and standardized across all regions.</td>
            </tr>
            <tr>
                <td class="pillar">Clinical Guidelines</td>
                <td>No national guidelines; treatment decisions vary widely by facility.</td>
                <td>Guidelines under development or loosely adopted; low adherence.</td>
                <td>National guidelines published; inconsistent implementation across hospitals.</td>
                <td>Guidelines enforced through audits, training, and digital systems.</td>
                <td>Fully integrated clinical pathways and real-time decision support tools in all institutions.</td>
            </tr>
        </table>
    </div>

    <div class="workflow-div">
        <h1>Study Approach & Index Overview</h1>
        <p>A Cross-Cancer Framework Built on Literature, Policy Data & Expert Validation</p>
        <div class="workflow">
            <div class="step">
                <h2>Data Collection & Review</h2>
                <ul>
                    <li>Comprehensive literature review: academic articles, peer-reviewed journals, policy reports, government documents</li>
                    <li>Official sources: national cancer control plans, Ministry of Health websites, WHO & IARC databases</li>
                    <li>Grey literature: NGO reports, advocacy group publications, etc.</li>
                </ul>
            </div>
            <div class="step">
                <h2>Pillar-Based Data Organization</h2>
                <ul>
                    <li>Information was mapped to 7 Pillars:</li>
                    <ul>
                        <li>Infrastructure</li>
                        <li>Treatment Access, Research & Awareness</li>
                        <li>Survival, Early Detection & Palliative Care</li>
                        <li>Utilization of Biomarkers</li>
                        <li>Clinical Guidelines</li>
                        <li>Reimbursement & Financial Access</li>
                        <li>Screening Programs</li>
                    </ul>
                    <li>Each pillar included 2-5 specific measures, assessed independently</li>
                </ul>
            </div>
            <div class="step">
                <h2>Scoring Methodology</h2>
                <ul>
                    <li>Quantitative and Qualitative Hybrid Scoring:</li>
                    <ul>
                        <li>1-5 Maturity Scale per measure:</li>
                        <ul>
                            <li>1 = Critical - Least Developed</li>
                            <li>2 = Emerging - Underdeveloped</li>
                            <li>3 = Intermediate - Developing</li>
                            <li>4 = Advanced - Well Developed</li>
                            <li>5 = Leading - Highly Developed</li>
                        </ul>
                    </ul>
                    <li>Biomarker Use scored by % availability (e.g., HER2, BRCA, EGFR)</li>
                    <li>Screening Programs assessed descriptively by scope, frequency, and implementation model</li>
                    <li>Country-level scores aggregated to produce:</li>
                    <ul>
                        <li>Pillar Scores (per cancer type)</li>
                        <li>Overall Maturity Level (per cancer type and across cancers)</li>
                    </ul>
                </ul>
            </div>
            <div class="step">
                <h2>Expert Validation</h2>
                <ul>
                    <li>180+ expert consultations with oncologists, policymakers, cancer registry managers, and public health leaders</li>
                    <li>Country visits to verify infrastructure & service delivery; structured stakeholder discussions</li>
                    <li>Conference engagement via online & offline workshops, forums, and symposia for feedback</li>
                    <li>Peer review by an international advisory group to ensure accuracy & consistency</li>
                </ul>
            </div>
            <div class="step">
                <h2>Results</h2>
                <ul>
                    <li>Factsheet & Policy Paper Development</li>
                    <ul>
                        <li>Country-level factsheets prepared from validated, scored data</li>
                        <li>Policy papers developed to translate findings into actionable recommendations</li>
                    </ul>
                    <li>Visual, structured outputs designed as practical references for policymakers, researchers, and advocates</li>
                </ul>
            </div>
        </div>
    </div>

</div>



<script>
    const cards = document.querySelectorAll('.goal-card');

    const observer = new IntersectionObserver(entries => {
        entries.forEach(entry => {
            if (entry.isIntersecting) {
                entry.target.classList.add('visible');
            }
        });
    }, {
        threshold: 0.1
    });

    cards.forEach(card => observer.observe(card));

</script>

{% endblock %}